Sivik Global Healthcare LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Sivik Global Healthcare LLC disclosed 34 US equity positions worth $131.7m in its Q1 2026 13F filing. The largest position was XBI at 14.5% of the reported book, followed by CAH and CALL- BSX 100 @ 75 EXP 04/17/2026.
What did Sivik Global Healthcare LLC own in Q1 2026? Top 34 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | XBI STATE STREET SPDR S&P BIOTECH | 14.5% | $19.2m | 150,000 | – | ||
| 2 | CAH CARDINAL HEALTH | Healthcare | 3.9% | $5.1m | 24,000 | – | |
| 3 | CALL- BSX 100 @ 75 EXP 04/17/2026 | 3.8% | $5.0m | 800 | – | ||
| 4 | JNJ JOHNSON&JOHNSON | Healthcare | 3.7% | $4.9m | 20,000 | – | |
| 5 | MRK MERCK & CO | Healthcare | 3.7% | $4.8m | 40,000 | – | |
| 6 | COR CENCORA INC | Healthcare | 3.6% | $4.7m | 15,000 | – | |
| 7 | LLY ELI LILLY & CO | Healthcare | 3.5% | $4.6m | 5,000 | – | |
| 8 | WAT WATERS CORP | Healthcare | 3.4% | $4.5m | 15,000 | – | |
| 9 | VRTX VERTEX PHARMACEUTICALS INC. | Healthcare | 3.4% | $4.5m | 10,000 | – | |
| 10 | ISRG INTUITIVE SURG | Healthcare | 3.2% | $4.1m | 9,000 | – | |
| 11 | AZN ASTRAZENECA PLC | Healthcare | 3.0% | $3.9m | 20,000 | – | |
| 12 | TMO THERMO FISHER SCIENTIFIC INC. | Healthcare | 3.0% | $3.9m | 8,000 | – | |
| 13 | BSX BOSTON SCIENTIFIC CORPORATION | Healthcare | 3.0% | $3.9m | 62,000 | – | |
| 14 | DHR DANAHER CORP | Healthcare | 2.9% | $3.8m | 20,000 | – | |
| 15 | THC TENET HEALTHCARE | Healthcare | 2.9% | $3.8m | 20,000 | – | |
| 16 | GILD GILEAD SCIENCES INC | Healthcare | 2.6% | $3.5m | 25,000 | – | |
| 17 | HUM HUMANA INC. | Healthcare | 2.6% | $3.5m | 20,000 | – | |
| 18 | MTD METTLER TOLEDO | Healthcare | 2.6% | $3.5m | 2,750 | – | |
| 19 | MCK MCKESSON CORP | Healthcare | 2.6% | $3.5m | 4,000 | – | |
| 20 | A AGILENT TECHNOLOGIES INC | Healthcare | 2.6% | $3.4m | 30,000 | – | |
| 21 | SYK STRYKER CORP | Healthcare | 2.5% | $3.3m | 10,000 | – | |
| 22 | ABBV ABBVIE INC | Healthcare | 2.5% | $3.3m | 15,000 | – | |
| 23 | UHS UNIV HEALTH SVC | Healthcare | 2.4% | $3.1m | 17,500 | – | |
| 24 | REGN REGENERON PHARMACEUTICALS | Healthcare | 2.3% | $3.1m | 4,000 | – | |
| 25 | BIO BIO-RAD LABS A | Healthcare | 2.1% | $2.8m | 10,000 | – | |
| 26 | BIIB BIOGEN INC | Healthcare | 2.1% | $2.8m | 15,000 | – | |
| 27 | UNH UNITEDHEALTH GRP | Healthcare | 2.1% | $2.7m | 10,000 | – | |
| 28 | GMED GLOBUS MEDICAL | Healthcare | 2.0% | $2.6m | 30,000 | – | |
| 29 | ABT ABBOTT LABS | Healthcare | 1.9% | $2.6m | 25,000 | – | |
| 30 | EW EDWARDS LIFESCIENCES | Healthcare | 1.2% | $1.6m | 20,000 | – | |
| 31 | SNN SMITH & NEPHEW | Healthcare | 1.2% | $1.6m | 50,000 | – | |
| 32 | ELV ELEVANCE HEALTH INC | Healthcare | 1.1% | $1.5m | 5,000 | – | |
| 33 | EHC ENCOMPASS HEALTH CORP | Healthcare | 1.1% | $1.5m | 15,000 | – | |
| 34 | CVS CVS HEALTH CORP | Healthcare | 1.1% | $1.4m | 20,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.